Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eton Pharmaceuticals (ETON) Other Non Operating Income (2021 - 2024)

Eton Pharmaceuticals' Other Non Operating Income history spans 3 years, with the latest figure at $169000.0 for Q4 2024.

  • For Q4 2024, Other Non Operating Income rose 121.13% year-over-year to $169000.0; the TTM value through Dec 2024 reached $169000.0, changed N/A, while the annual FY2024 figure was $169000.0, N/A changed from the prior year.
  • Other Non Operating Income for Q4 2024 was $169000.0 at Eton Pharmaceuticals, up from -$800000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $800000.0 in Q2 2023 and bottomed at -$800000.0 in Q4 2023.
  • The 3-year median for Other Non Operating Income is $267000.0 (2021), against an average of $133500.0.
  • The largest YoY upside for Other Non Operating Income was 121.13% in 2024 against a maximum downside of 121.13% in 2024.
  • A 3-year view of Other Non Operating Income shows it stood at $365000.0 in 2021, then tumbled by 319.18% to -$800000.0 in 2023, then surged by 121.12% to $169000.0 in 2024.
  • Per Business Quant, the three most recent readings for ETON's Other Non Operating Income are $169000.0 (Q4 2024), -$800000.0 (Q4 2023), and $800000.0 (Q2 2023).